COR.NYSECencora, INC

Form 4: Cencora EVP Campbell Reports RSU Vesting & Tax Sales

Sentiment:

Insider Transaction Report


Cencora Executive Vice President Elizabeth S. Campbell reported the vesting of restricted stock units and subsequent sales to cover tax obligations.

Summary

  • Elizabeth S. Campbell, Executive Vice President of Cencora, Inc., reported transactions related to her beneficial ownership of common stock.
  • On November 7, 2025, Campbell acquired 2,023 shares of common stock upon the vesting of restricted stock units.
  • Concurrently, 798 shares were disposed of at $360.7 per share to satisfy tax withholding obligations related to the RSU vesting.
  • On the same date, Campbell acquired an additional 1,830 shares of common stock from another RSU vesting event.
  • Following this, 572 shares were disposed of at $360.7 per share to cover tax withholding obligations for the second RSU vesting.
  • After these transactions, Campbell's direct beneficial ownership of Cencora common stock stands at 15,307.141 shares.
  • The restricted stock units (RSUs) that led to these transactions were part of grants with vesting schedules extending to November 8, 2026.

Sentiment

Score: 6

Explanation: The filing reports routine executive compensation events (RSU vesting and tax-related sales), which are expected and do not indicate any significant positive or negative operational or financial news for the company. It confirms ongoing executive equity alignment.

Positives

  • The acquisition of shares through RSU vesting indicates continued equity participation by an executive.
  • The transactions are routine and expected for executive compensation plans, demonstrating standard corporate governance.

Negatives

  • The disposition of shares, although for tax purposes, reduces the executive's direct shareholding.

Future Outlook

Future vesting events for restricted stock units are scheduled through November 8, 2026, suggesting continued long-term incentive alignment for the executive.

Industry Context

This Form 4 filing reflects routine executive compensation practices common across publicly traded companies, particularly in the pharmaceutical and healthcare services industry where Cencora operates. The use of restricted stock units is a standard mechanism for aligning executive incentives with shareholder value over the long term.

Comparison to Industry Standards

  • The RSU vesting and subsequent tax-related sales are standard practices in executive compensation across various industries, including healthcare distribution.
  • Companies like Cardinal Health (CAH) and McKesson Corporation (MCK), Cencora's peers, also utilize similar equity compensation structures for their executives, leading to comparable Form 4 filings for RSU vesting and tax-related dispositions.

Related Party Transactions

  • The reported transactions represent an insider (Elizabeth S. Campbell, Executive Vice President) acquiring and disposing of company stock, which is inherently a related party transaction.

Stakeholder Impact

  • Shareholders: This report provides transparency regarding executive stock ownership and compensation, which is beneficial for shareholders. The slight reduction in direct ownership due to tax sales is a routine event and not indicative of a lack of confidence.
  • Management: Confirms the ongoing equity compensation structure for the Executive Vice President.

Next Steps

  • Future vesting events for restricted stock units are scheduled for November 9, 2025, November 8, 2025, and November 8, 2026.

Key Dates

DateDescription
11/09/2023First installment vesting date for a grant of restricted stock units (related to the 2,023 shares acquired).
11/08/2024First installment vesting date for another grant of restricted stock units (related to the 1,830 shares acquired).
11/09/2024Second installment vesting date for a grant of restricted stock units (related to the 2,023 shares acquired).
11/07/2025Transaction date for the acquisition of common stock upon RSU vesting and subsequent disposition for tax withholding.
11/08/2025Second installment vesting date for a grant of restricted stock units (related to the 1,830 shares acquired).
11/09/2025Third installment vesting date for a grant of restricted stock units (related to the 2,023 shares acquired).
11/12/2025Date the Form 4 was signed by Elizabeth S. Campbell.
11/08/2026Third installment vesting date for a grant of restricted stock units (related to the 1,830 shares acquired).

Recommendation

hold

This Form 4 filing details routine executive compensation events involving the vesting of restricted stock units and subsequent sales to cover tax obligations. Such transactions are expected and typically pre-scheduled, offering no new fundamental information about Cencora's operational performance or future prospects. Therefore, it does not warrant a change in investment recommendation based solely on this filing.

Keywords

Cencora, COR, Form 4, Insider Trading, Restricted Stock Units, RSU Vesting, Executive Compensation, Stock Transactions, Elizabeth S. Campbell, Tax Withholding

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.